Marginal dietary thiamin deficiency induces the formation of colonic aberrant crypt foci (ACF) in rats

Cancer Letters

Volumn 202, Issue 2, 2003, Pages 125-129

  Bruce, W Robert ^a   Furrer, Rudolf ^a   Shangari, Nandita ^a   O'Brien, Peter J ^a   Medline, Alan ^b   Wang, Yanping ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c YORK UNIVERSITY   (Canada)

Author keywords

Aberrant crypt foci; Colon cancer; Thiamin deficiency; Transketolase; Oxoaldehydes

Indexed keywords

CARCINOGEN; SUCROSE; THIAMINE;

ABERRANT CRYPT FOCI; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BERIBERI; CANCER RISK; CARCINOGENESIS; COLON CANCER; CONTROLLED STUDY; DIET; EXAMINATION; INTESTINE CRYPT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SYMPTOM; THIAMINE DEFICIENCY;

EID: 0345303978     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2003.08.005     Document Type: Article

References (36)

1. 1 eine intoxikation mit methylglyoxal? Biochem. Z. 233:1931;248-250.
2. Wako H. Isolation and identification of methyl glyoxal from human milk, preliminary report, Tohoku. J. Exp. Med. 55:1951;34.
3. Williams R.R., Spies T.D. Vitamin B1 (Thiamin) and its Use in Medicine. 1938;MacMillan, New York. pp. 356-370.
4. Salem H.M. Glyoxalase and methylglyoxal in thiamine-deficient rats. Biochem. J. 57:1954;227-230.
5. Thornally P.J., Jahan I., Ng R. Suppression of the accumulation of triosphosphates and increased formation of methylglyoxal in human red blood cells during hyperglycemia by thiamine in vitro. J. Biochem. 129:2001;543-549.
6. Richard J.P. Acid-base catalysis of the elimination and isomerization reactions of triose phosphates. J. Am. Chem. Soc. 106:1984;4926-4936.
7. Rose I.A., Nowick J.S. Methylglyoxal synthetase, enol-pyruvaldehyde, glutathione and the glyoxalase system. J. Am. Chem. Soc. 124:2002;13047-13052.
8. Blair P.V., Kobayashi R., Edwards H.M., Shay N.F., Baker D.H., Haris R.A. Dietary thiamin level influences levels of its diphosphate form and thiamin-dependent enzymic activities in rat liver. J. Nutr. 129:1999;641-648.
9. Hsu J.M., Chow B.F. Effect of thiamine deficiency on glutathione content of erythrocytes and tissues in the rat. Proc. Soc. Exp. Biol. Med. 104:1960;178-180.
10. Thornally P.J. Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxication - a role in pathogenesis and antiproliferative chemotherapy. Gen. Pharmacol. 27:1996;565-571.
11. Murata-Kamiya N., Kamiya H., Kaji H.K., Kasai H. Methylglyoxal induces G:C to C:G and G:C to T:A transversions in the supF gene on a shuttle vector plasmid replicated in mammalian cells. Mutat. Res. 468:2000;173-182.
12. Hou S.M., Nori P., Fang J.L., Vaca C.E. Methylglyoxal induces hprt mutation and DNA adducts in human T-lymphocytes in vitro. Environ. Mol. Mutagen. 26:1995;286-291.
13. Migliore L., Barale R., Boseo E., Giorgelli F., Minunni M., Scarpato R., Loprieno N. Genotoxicity of methylglyoxal: cytogenetic damage in human lymphocytes in vitro and in intestinal cells of mice. Carcinogenesis. 11:1990;1503-1507.
14. Nagao M., Fujita Y., Sugimura T., Kosuge T. Methyl glyoxal in beverages and foods: its mutagenicity and carcinogenicity. IARC Sci. Publ. 70:1986;283-291.
15. Kritchevsky D. Influence of caloric restriction and exercise on tumorigenesis in rats. Proc. Soc. Exp. Biol. Med. 193:1990;35-38.
16. McLellan E.A., Medline A., Bird R.P. Sequential analyses of the growth and morphological characteristics of aberrant crypt foci: putative preneoplastic lesions. Cancer Res. 51:1991;5270-5274.
17. Tudek B., Bird R.P., Bruce W.R. Foci of aberrant crypts in the colons of mice and rats exposed to carcinogens associated with foods. Cancer Res. 49:1989;1236-1240.
18. Whiteley L.O., Hudson L. Jr., Pretlow T.P. Aberrant crypt foci in the colonic mucosa of rats treated with genotoxic and non-genotoxic carcinogen. Toxicol. Pathol. 24:1996;681-689.
19. Corpet D.E., Tache S. Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency. Nutr. Cancer. 43:2002;1-21.
20. Bouzourene H., Chaubert P., Seelentag W., Bosman F.T., Saraga E. Aberrant crypt foci in patients with neoplastic and non-neoplastic colonic disease. Hum. Pathol. 30:1999;66-71.
21. Shpitz B., Hay K., Medline A., Bruce W.R., Bull S.B., Gallinger S., Stern H. Natural history of aberrant crypt foci. A surgical approach. Dis. Colon Rectum. 39:1996;763-767.
22. Nutrient requirement of the laboratory rat. In Nutrient Requirement of Laboratory Animals. 1995;National Academy Press, Washington DC. pp. 11-79.
23. Rains T.M., Emmert J.L., Baker D.H., Shay N.F. Minimum thiamin requirement of weanling Sprague-Dawley outbred rats. J. Nutr. 127:1997;167-170.
24. Bieri J.G. AIN-76 diet. J. Nutr. 109:1979;925-926.
25. Warnock L.G. A new approach to erythrocyte transketolase measurement. J. Nutr. 100:1970;1957-1962.
26. Bruce W.R., Archer M.C., Corpet D.E., Medline A., Minkin S., Stamp D., et al. Diet, aberrant crypt foci and colorectal cancer. Mutat. Res. 290:1993;111-118.
27. Hayashi M., Morita T., Kodama Y., Sofuni T., Ishidate I. The micronuclus assay with mouse peripheral blood reticulocytes using acridine orange-coated slides. Mutat. Res. 245:1990;245-249.
28. Tagliaferro A.R., Levitsky D.A. Spillage behavior and thiamin deficiency in the rat. Physiol. Behav. 28:1982;933-937.
29. Dragsted L.O., Daneshvar B., Vogel U., Autrup H.N., Wallin H., Risom L., et al. A sucrose-rich diet induces mutations in the rat colon. Cancer Res. 62:2002;4339-4345.
30. Zhang X.M., Chan C.C., Stamp D., Minkin S., Archer M.C., Bruce W.R. Initiation and promotion of colonic aberrant crypt foci in rats by 5-hydroxymethyl-2-furaldehyde in thermolyzed sucrose. Carcinogenesis. 14:1993;773-775.
31. Yang C.M., Kendal C.W., Stamp D., Medline A., Archer M.C., Bruce W.R. Thermally oxidized dietary fat and colon carcinogenesis in rodents. Nutr. Cancer. 30:1998;69-73.
32. Thiamin. In Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. 1999;Food and Nutrition Board, Institute of Medicine, National Academy Press, Washington, DC. pp. 58-86.
33. Drewnowski A. Fat and sugar: an economic analysis. J. Nutr. 133:2003;838S-840S.
34. Bakker S.J., Hoogeveen E.K., Nijpels G., Kostense P.J., Dekker J.M., Gans R.O., Heine R.J. The association of dietary fibers with glucose tolerance is partly explained by concomitant intake of thiamine: the Hoorn Study. Diabetologia. 41:1998;1168-1175.
35. Mascher H.J., Kikuta C. High-performance liquid chromatography determination of total thiamin in human plasma. Methods Enzymol. 279:1997;83-90.
36. Comy-n-Anduix B., Boren J., Martinez S., Moro C., Centelles J.J., Trebukhina R., et al. The effect of thiamine supplementation on tumor proliferation: a metabolic control analysis study. Eur. J. Biochem. 268:2001;4177-4182.